My HPRA: Register

LAMIVUDINE/ZIDOVUDINE TEVA

150/300 Milligram Film Coated Tablet

Teva B.V.EU/1/10/663/001-002

Main Information

Trade NameLAMIVUDINE/ZIDOVUDINE TEVA
Active SubstancesLAMIVUDINE
ZIDOVUDINE
Strength150/300 Milligram
Dosage FormFilm Coated Tablet
Licence HolderTeva B.V.
Licence NumberEU/1/10/663/001-002

Group Information

ATC CodeJ05AR01 Antivirals for treatment of HIV infections, combinations

Status

Authorised/WithdrawnAuthorised
Licence Issued28/02/2011
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing Status--Unknown--
Promotion StatusPromotion to Healthcare Professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back
Follow medicine

Print